Skip to main content

Deal Alert: Rajasthan Venture invests Rs. 20 crores in International Oncology

From the Press Release:

Jaipur-based Rajasthan Venture Capital Fund (RVCF) has invested Rs 20 crores in International Oncology Services Private Limited (IOSPL), a super specialty cancer care company for an undisclosed equity stake. 

International Oncology has established comprehensive cancer care centres (known as International Oncology Centre) equipped with cutting edge technology at Fortis Hospital, Noida and Dr. L H Hiranandani Hospital, Mumbai. The company with an objective to make quality cancer care more accessible to the people has identified several cities in India for setting up world class cancer care centers and opening soon its next centers in Jodhpur, Rajasthan and Jalandhar, Punjab.

“The Oncology sector is currently witnessing a huge gap in terms of incidence of cancer in the country and limited quality cancer care facilities to treat the same. While the incidence of cancer is increasing at an alarming rate in India; the country faces large limitations in terms of lack of technical specialization and trained personnel. India has few public sector cancer centres, some central establishment and limited private sector participation. IOSPL through its specialized cancer care centres is set to address this burgeoning demand in India” said Mr. Rajendra Bhanawat, Chairman of RVCF. 

Mr. Pradeep K Jaisingh, CEO and MD of International Oncology Services Pvt. Ltd. said, “After setting up comprehensive cancer centres in NCR and Mumbai, we are in the process of taking world class cancer care to several other states of India and Rajasthan is a special focus area for us. This investment by RVCF will help IOSPL carry out its immediate expansion plans and we are delighted to have their support." 

“IOSPL with its professional and experienced promoters & team is expected to emerge as one of the leading cancer care company in India” said Mr. Girish Gupta, CEO of RVCF who will be joining the Board of Directors of the company. 

RVCF has invested in IOSPL through its Rs 200 crores SME Tech Fund which invests pan India in IT, education, healthcare, agro products, auto components and other growth sectors. 

ABOUT IOSPL 

International Oncology is a global cancer care and research company focused on providing world class cancer treatment and care. The company is at the forefront of bringing the very best in cancer care to India through expertise, research and collaboration. International Oncology is committed to making world class cancer care accessible to the underserved areas through their network of cancer care centres. 

After establishing their flagship centres at Noida and Mumbai, the company is in the process of launching comprehensive cancer care centres in states like Rajasthan, Punjab, Maharashtra and others. In the outreach programme, the company has tied up with various hospitals in Aligarh, Moradabad, Srinagar, Imphal, Gwalior and Panipat to make world class cancer care more accessible. 

ABOUT RVCF 

Rajasthan Venture Capital Fund is mandated to operate on pan-India basis. It manages two SEBI registered domestic venture capital funds - RVCF Fund I & SME TECH FUND – RVCF Trust II and invests in IT, education, healthcare, agro products, auto components and other growth sectors. Rajasthan Venture Capital Fund is amongst the top 3 Regional venture capital funds in India.

For more details contact Mr. Girish Gupta, CEO – Rajasthan Venture
Mobile No: +91 98290 66878/ Landline: 0141-4071680

Popular posts from this blog

PE-VC investments in Q2'23 decline 33% to $9.9 Billion

Private Equity-Venture Capital (PE-VC) investments in India during the quarter ended June 2023 (Q2'23), at $9.85 Billion across 182 deals, registered a 33% decrease compared to the same period in 2022 (which saw $14.6 Billion being invested across 371 deals). The investment amount however rose 74% compared to the immediate previous quarter (which saw $5.7 Billion being invested across 181 deals), shows data from  Venture Intelligence , a research service focused on private company financials, transactions, and their valuations. The PE-VC investment figures for the first 6 months of 2023 - at $15.5 Billion (across 363 deals) - was 50% lower compared to the same period in 2022 (which saw $31 Billion being invested across 800 deals). Q2’23 witnessed 19 mega deals ($100 M+

Chiratae, Speciale and Stride Ventures win APEX'24 Venture Capital Awards

Chiratae Ventures, Speciale Invest and Stride Ventures were awarded as among the leading Venture Capital investors in India for 2023 as part of Venture Intelligence APEX‘24 Private Equity & Venture Capital awards event in Mumbai.  The Venture Intelligence “Awards for Private Equity Excellence” (APEX) is dedicated to celebrating the best that the Indian Private Equity & Venture Capital industry has to offer. The APEX Awardees are selected based on both Self Nomination by the participating PE-VC firms and "crowd sourced" voting from the Limited Partner, PE-VC and advisory communities. (The main criteria are Return Track Record, New Fund Raises & Follow-on Funding Rounds for Portfolio Companies) VC Investor of the Year Chiratae Ventures received the Venture Capital Investor of the Year 2023 Award on the back of 10 part exits totaling $178 million via Secondary Sales during the year. Its exits included those from retail unicorn Lenskart, SaaS Startup Pixis and baby pr

Blackstone, MO Alts and InvAscent win APEX'24 Private Equity Awards

Press Release Blackstone, MO Alternates (formerly Motilal Oswal PE) and InvAscent were awarded as among the leading Private Equity and Growth Capital investors in India for 2023 as part of Venture Intelligence APEX‘24 Private Equity & Venture Capital awards event in Mumbai.  The Venture Intelligence “Awards for Private Equity Excellence” (APEX) is dedicated to celebrating the best that the Indian Private Equity & Venture Capital industry has to offer. The APEX Awardees are selected based on both Self Nomination by the participating PE-VC firms and "crowd sourced" voting from the Limited Partner, PE-VC and advisory communities. (The main criteria are Return Track Record, New Fund Raises & Follow-on Funding Rounds for Portfolio Companies) PE Investor of the Year Blackstone received the Private Equity Investor of the Year 2023 Award on the back of strong complete exits during the year: from Sona Comstar and IBS Software. Ganesh Mani and Amit Dalmia, Senior Managing D

Avendus tops League Table for Transaction Advisors to PE deals in Q1'23

Aeka Advisors and Ambit claim the No.2 & 3 slot Avendus topped the Venture Intelligence League Table for Transaction Advisor to Private Equity Transactions for Q1 2023 advising 5 deals worth $808 million. Aeka Advisors stood second having advised 3 deals worth $228 million. Ambit followed with 4 deals worth $160 million. Ernst & Young ($114 million across 4 deals) and o3 Capital ($80 million across 2 deals) completed the top five for Q1 2023. Avendus acted as advisor to ADIA’s $500 million investment in omnichannel eyewear retailer Lenskart . Aeka Advisors acted as advisor to Kreditbee’s $160 million fundraise from Advent International, Mitsubishi UFJ Financial Group (MUFG) and existing investors. Ambit advised the $104 million fundraise of Freshtohome from Mount Judi Ventures, Iron Pillar, Amazon and others. The  Venture Intelligence League Tables , the first such initiative exclusively tracking transactions involving India-based companies, are based on the value of PE

PE-VC investments fall 38% in 2023 to below $30 B

The value of investments by Private Equity - Venture Capital (PE-VC) firms in India fell by 38% to less than $30 Billion in 2023. PE-VC firms invested $29.7 Billion (across 756 deals) in Indian companies in 2023, compared to $47.6 Billion (across 1,362 deals) in the previous year, reports Venture Intelligenc e, a research service focused on private company financials, transactions, and their valuations. (Note: These figures exclude PE investments in Real Estate).                                                                                                                                                                      2023 witnessed 67 mega deals ($100 M+ rounds) worth $21.2 Billion, compared to 112 such investments worth $31.8 Billion in 2022. The $2.4 Billion investment in Manipal Hospitals by Temasek (which gained majority control) and TPG Capital was the largest PE-VC investment in 2023. This was followed by the $1.35 Billion buyout of education loans focused HDFC Credila